Crowdonomics
WatchlistPortfolio
TAXA Biotechnologies, Inc

Reg CF · SAFE · May 2016

ClosedReg CFSAFE
via WeFunder · last checked Aug 17, 2026
Raised
$309.8K / $1M max
31% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2014–FY2015 · hover for source
$1K
−$361K
FY2014
$6K
−$299K
FY2015
RevenueNet income
Metric
FY2014 reviewed*
FY2015 reviewed*
Income statement
Revenue
$1,115
$5,694
Cost of goods sold
$0
$0
Gross margin
100%
100%
Net income
-$361,237
-$298,573
Taxes paid
$0
$1,247
Balance sheet
Cash
$432,140
$193,376
Accounts receivable
$0
$1,097
Total assets
$441,532
$230,909
Short-term debt
$569,251
$589,120
Long-term debt
$441,532
$423,000
Total liabilities
$1,010,783
$1,012,120
Other
Headcount
—
3

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

3 amendments
  1. Aug 2, 2016
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  2. Jun 1, 2016
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  3. Jun 1, 2016
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$400,000
Max$1,000,000
Min investment—
OpenedMay 16, 2016
DeadlineNov 12, 2016
ClosedNov 12, 2016
Days active180

Links & provenance

SEC filing
Source: SEC EDGAR
0001670254-16-000002
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.